Blossomhill Therapeutics
Clinical trials sponsored by Blossomhill Therapeutics, explained in plain language.
-
New hope for lung cancer: targeted drug BH-30643 enters human trials
Disease control Recruiting nowThis study tests a new drug, BH-30643, in adults with advanced non-small cell lung cancer that has certain gene changes (EGFR or HER2 mutations). The goal is to find a safe dose and see if the drug can shrink tumors. About 266 people will take part across multiple locations.
Phase: PHASE1, PHASE2 • Sponsor: BlossomHill Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New pill takes on tough blood cancers in first human trial
Disease control Recruiting nowThis early-phase trial tests an experimental oral drug called BH-30236 in adults with relapsed or refractory acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS). The study first tests BH-30236 alone, then in combination with another drug, venetoclax. About 17…
Phase: PHASE1 • Sponsor: BlossomHill Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC